Biocon Ltd. — Regulatory Filings 2020

Nov 20, 2020

==> picture [88 x 35] intentionally omitted <==

Biocon Limited 20th KM, Hosur Road Electronic City Bangalore 560 100, India T 91 80 2808 2808 F 91 80 2852 3423

CIN : L24234KA1978PLC003417

www.biocon.com

November 20, 2020

To The Secretary BSE Limited Department of Corporate Services Phiroze Jeejeebhoy Towers, Dalal Street,Mumbai – 400 001	To The Secretary National Stock Exchange of India Limited Corporate Communication Department Exchange Plaza, Bandra Kurla Complex Mumbai – 400 050
Scrip Code - 532523	Scrip Symbol - BIOCON

Dear Sir/Madam,

Sub: Meetings conducted with Institutional Investors/Research Analysts.

Ref: Intimation under Regulation 30 (6) of SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015.

Pursuant to Regulation 30 (6) of the SEBI LODR Regulations, 2015, we hereby inform you that the following meetings were conducted with Institutional Investor / Research Analysts:

Date	Name	Type of meeting	Location
November 19, 2020	Kotak Mahindra Ishana Capital IDFC IIFL AMC Spark Capital Advisors PGIM India AMC Neuberger Berman PNB MetLife WhiteOak Doric Capital Corporation Aditya Birla SunLife Mutual Fund L&T Mutual Fund SBI Pension Fund Iroha Investment Management OMERS SBI Mutual Fund Old Bridge Capital New Horizon Tata AIA Life Insurance Company Amansa Arohi Asset Management	Teleconference	Bangalore

We request you to kindly take above intimation on record.

Thanking You,

Yours faithfully,

For Biocon Limited

==> picture [76 x 32] intentionally omitted <==

==> picture [70 x 74] intentionally omitted <==

---

Mayank Verma

Company Secretary and Compliance Officer